Radius Health (RDUS): Rega marang dodolan

Logo korporat perusahaan Radius Health (RDUS)

Against the backdrop of the global transition to a circular metal economy, the current P/S dynamics on GURU.Markets establish the 0.30 level, which reflects the state of the market valuation parameter. Radius Recycling, Inc. (RDUS) brand expertise in treating bone pathologies earns physician trust, while stable demand for the drug Tymlos ensures high cash flow margins, confirming the fundamental resilience of the business.

Radius Recycling - Multiplikator P/S RDUS (periode 04.07.2022 - 26.07.2025)

Rincian metrik lan analitis perusahaan Radius Health (RDUS)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:radiuspharm.com, RDUS
Barang utama Radius Recycling, Inc.

Radius Recycling, Inc. (RDUS) occupies a stable niche in the scrap metal recycling cycle, where the efficiency of converting decommissioned equipment into raw materials directly determines market value. Analyzing P/S fluctuations allows for an assessment of how many dollars of market capitalization the market assigns to each dollar of revenue, revealing whether the asset is overbought or carries a hidden discount relative to US industry standards for long-term planning.

Perusahaan pesaing

Rasio rega marang pendapatan ASND (ascendispharma.com)|Rasio rega marang pendapatan Madrigal Pharmaceuticals, Inc. MDGL|Corcept Therapeutics Inc. (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics|NewAmsterdam Pharma Company (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Soleno (SLNO)|Kapitalisasi marang pendapatan Amicus Corp FOLD|Rasio rega marang pendapatan 89bio, Inc. ETNB|Rasio kapitalisasi pasar marang pendapatan AGIO|Structure Therapeutics Inc. - Multiplikator P/S|MDXG - Multiplikator P/S|RZLT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan LXRX|MBX (MBX Biosciences Inc) - Multiplikator P/S|altimmune.com (ALT) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan AARD (Aardvark Therapeutics)|Multiplikator P/S Sagimet Biosciences, Inc. (SGMT)|Rasio rega marang pendapatan BioAge Labs Inc. BIOA|Koefisien rega marang pendapatan Biomea Fusion Corp (BMEA)|QNCX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan GUTS (fractyl.com)|vtvtherapeutics.com (VTVT) - Rasio rega marang pendapatan|Agape ATP - Rasio kapitalisasi pasar marang pendapatan|PLUR (Pluristem Therapeutics) - Multiplikator P/S|Rega marang dodolan Synlogic Corp SYBX|Multiplikator P/S LPCN|Kapitalisasi marang pendapatan matinasbiopharma.com MTNB|Spruce Biosciences, Inc. - Kapitalisasi marang pendapatan|Galecto Inc (GLTO) - Rega marang dodolan|Carmell Corp - Multiplikator P/S|Lumos Therapeutics (LUMO) - Kapitalisasi marang pendapatan|Organovo Holdings, Inc. (ONVO) - Rasio rega marang pendapatan